Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | PTGX | LEGN | ||
| Company | Reata Pharma | Protagonist Therapeutics Inc | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 103.14 | 34.29 | ||
| High | 172.46 | 103.29 | 34.86 | ||
| Low | 172.32 | 96.38 | 32.59 | ||
| Latest | 172.36 | 97.38 | 32.62 | ||
| Change | +0.04 | -5.41 | -1.58 | ||
| % Change | +0.02% | -5.26% | -4.62% | ||
| Volume | 1,988,500 | 887,396 | 2,484,485 | ||
| 20-Day Average Volume | 810,510 | 545,845 | 3,006,489 | ||
| Previous Close | 172.32 | 102.79 | 34.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 100.07 | 29.21 | ||
| 20-Day Raw Stochastic | 97.36% | 35.70% | 63.03% | ||
| 20-Day Relative Strength | 81.56 | 47.79 | 60.99 | ||
| Weighted Alpha | +177.60 | +55.43 | +10.38 | ||
| Today's Opinion | 100% Buy | 40% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 96% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -2.19% since 05/29/26 | +20.10% since 05/29/26 | ||
| Low | 171.96 on 09/19/23 | 92.75 on 06/02/26 | 24.81 on 06/01/26 | ||
| High | 172.46 on 09/25/23 | 103.54 on 06/04/26 | 37.50 on 06/03/26 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -1.84% since 05/05/26 | +14.42% since 05/05/26 | ||
| Low | 168.67 on 09/05/23 | 92.75 on 06/02/26 | 24.30 on 05/12/26 | ||
| High | 172.46 on 09/25/23 | 105.72 on 05/14/26 | 37.50 on 06/03/26 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +6.53% since 03/05/26 | +83.77% since 03/05/26 | ||
| Low | 88.80 on 06/27/23 | 87.82 on 03/06/26 | 16.70 on 03/30/26 | ||
| High | 172.46 on 09/25/23 | 107.84 on 04/01/26 | 37.50 on 06/03/26 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +8.62% since 12/05/25 | +15.96% since 12/05/25 | ||
| Low | 76.54 on 05/10/23 | 77.00 on 02/23/26 | 16.24 on 02/04/26 | ||
| High | 172.46 on 09/25/23 | 107.84 on 04/01/26 | 37.50 on 06/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,610,527 | 6,352,308 | ||
| Shares Outstanding, K | 38,150 | 64,311 | 185,740 | ||
| Annual Sales | 2,220,000 | 46,020,000 | 1,028,900,000 | ||
| Annual Net Income | -311,900,000 | -130,150,000 | -296,800,000 | ||
| Last Quarter Sales | 22,750,000 | 56,370,000 | 305,100,000 | ||
| Last Quarter Net Income | 193,000,000 | 3,780,000 | -54,300,000 | ||
| 60-Month Beta | 1.42 | 1.85 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 0.05 on 05/05/26 | -0.15 on 05/12/26 | ||
| Earnings Date | 11/14/23 | 08/05/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||